Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
Tutt, Andrew, Tovey, Holly, Cheang, Maggie Chon U, Kernaghan, Sarah, Kilburn, Lucy, Gazinska, Patrycja, Owen, Julie, Abraham, Jacinta, Barrett, Sophie, Barrett-Lee, Peter, Brown, Robert, Chan, Stephen, Dowsett, Mitchell, Flanagan, James M, Fox, Lisa, Grigoriadis, Anita, Gutin, Alexander, Harper-Wynne, Catherine, Hatton, Matthew Q, Hoadley, Katherine A, Parikh, Jyoti, Parker, Peter, Perou, Charles M, Roylance, Rebecca, Shah, Vandna, Shaw, Adam, Smith, Ian E, Timms, Kirsten M, Wardley, Andrew M, Wilson, Gregory, Gillett, Cheryl, Lanchbury, Jerry S, Ashworth, Alan, Rahman, Nazneen, Harries, Mark, Ellis, Paul, Pinder, Sarah E, Bliss, Judith M
Published in Nature medicine (01.05.2018)
Published in Nature medicine (01.05.2018)
Get full text
Journal Article
Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes
Timms, Kirsten M, Abkevich, Victor, Hughes, Elisha, Neff, Chris, Reid, Julia, Morris, Brian, Kalva, Saritha, Potter, Jennifer, Tran, Thanh V, Chen, Jian, Iliev, Diana, Sangale, Zaina, Tikishvili, Eliso, Perry, Michael, Zharkikh, Andrey, Gutin, Alexander, Lanchbury, Jerry S
Published in Breast cancer research : BCR (01.01.2014)
Published in Breast cancer research : BCR (01.01.2014)
Get full text
Journal Article
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
Telli, Melinda L, Timms, Kirsten M, Reid, Julia, Hennessy, Bryan, Mills, Gordon B, Jensen, Kristin C, Szallasi, Zoltan, Barry, William T, Winer, Eric P, Tung, Nadine M, Isakoff, Steven J, Ryan, Paula D, Greene-Colozzi, April, Gutin, Alexander, Sangale, Zaina, Iliev, Diana, Neff, Chris, Abkevich, Victor, Jones, Joshua T, Lanchbury, Jerry S, Hartman, Anne-Renee, Garber, Judy E, Ford, James M, Silver, Daniel P, Richardson, Andrea L
Published in Clinical cancer research (01.08.2016)
Published in Clinical cancer research (01.08.2016)
Get full text
Journal Article
Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes
Hodgson, Darren R, Dougherty, Brian A, Lai, Zhongwu, Fielding, Anitra, Grinsted, Lynda, Spencer, Stuart, O'Connor, Mark J, Ho, Tony W, Robertson, Jane D, Lanchbury, Jerry S, Timms, Kirsten M, Gutin, Alexander, Orr, Maria, Jones, Helen, Gilks, Blake, Womack, Chris, Gourley, Charlie, Ledermann, Jonathan, Barrett, J Carl
Published in British journal of cancer (01.11.2018)
Published in British journal of cancer (01.11.2018)
Get full text
Journal Article
Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer
Lotan, Tamara L., Kaur, Harsimar B., Salles, Daniela C., Murali, Sanjana, Schaeffer, Edward M., Lanchbury, Jerry S., Isaacs, William B., Brown, Robert, Richardson, Andrea L., Cussenot, Olivier, Cancel-Tassin, Geraldine, Timms, Kirsten M., Antonarakis, Emmanuel S.
Published in Modern pathology (01.06.2021)
Published in Modern pathology (01.06.2021)
Get full text
Journal Article
Homologous Recombination Deficiency: Concepts, Definitions, and Assays
Stewart, Mark D, Merino Vega, Diana, Arend, Rebecca C, Baden, Jonathan F, Barbash, Olena, Beaubier, Nike, Collins, Grace, French, Tim, Ghahramani, Negar, Hinson, Patsy, Jelinic, Petar, Marton, Matthew J, McGregor, Kimberly, Parsons, Jerod, Ramamurthy, Lakshman, Sausen, Mark, Sokol, Ethan S, Stenzinger, Albrecht, Stires, Hillary, Timms, Kirsten M, Turco, Diana, Wang, Iris, Williams, J Andrew, Wong-Ho, Elaine, Allen, Jeff
Published in The oncologist (Dayton, Ohio) (11.03.2022)
Published in The oncologist (Dayton, Ohio) (11.03.2022)
Get full text
Journal Article
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer
Isakoff, Steven J, Mayer, Erica L, He, Lei, Traina, Tiffany A, Carey, Lisa A, Krag, Karen J, Rugo, Hope S, Liu, Minetta C, Stearns, Vered, Come, Steven E, Timms, Kirsten M, Hartman, Anne-Renee, Borger, Darrel R, Finkelstein, Dianne M, Garber, Judy E, Ryan, Paula D, Winer, Eric P, Goss, Paul E, Ellisen, Leif W
Published in Journal of clinical oncology (10.06.2015)
Published in Journal of clinical oncology (10.06.2015)
Get full text
Journal Article
Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular Characterization
Lheureux, Stephanie, Lai, Zhongwu, Dougherty, Brian A, Runswick, Sarah, Hodgson, Darren R, Timms, Kirsten M, Lanchbury, Jerry S, Kaye, Stan, Gourley, Charlie, Bowtell, David, Kohn, Elise C, Scott, Claire, Matulonis, Ursula, Panzarella, Tony, Karakasis, Katherine, Burnier, Julia V, Gilks, C Blake, O'Connor, Mark J, Robertson, Jane D, Ledermann, Jonathan, Barrett, J Carl, Ho, Tony W, Oza, Amit M
Published in Clinical cancer research (01.08.2017)
Published in Clinical cancer research (01.08.2017)
Get full text
Journal Article
Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer
GONZALEZ-ANGULO, Ana M, TIMMS, Kirsten M, HORTOBAGYI, Gabriel N, DO, Kim-Anh, MILLS, Gordon B, MERIC-BERNSTAM, Funda, SHUYING LIU, HUIQIN CHEN, LITTON, Jennifer K, POTTER, Jennifer, LANCHBURY, Jerry S, STEMKE-HALE, Katherine, HENNESSY, Bryan T, ARUN, Banu K
Published in Clinical cancer research (01.03.2011)
Published in Clinical cancer research (01.03.2011)
Get full text
Journal Article
Biomarker Assessment of HR Deficiency, Tumor BRCA1/2 Mutations, and CCNE1 Copy Number in Ovarian Cancer: Associations with Clinical Outcome Following Platinum Monotherapy
Stronach, Euan A, Paul, James, Timms, Kirsten M, Hughes, Elisha, Brown, Krystal, Neff, Christopher, Perry, Michael, Gutin, Alexander, El-Bahrawy, Mona, Steel, Jennifer H, Liu, Xinxue, Lewsley, Liz-Anne, Siddiqui, Nadeem, Gabra, Hani, Lanchbury, Jerry S, Brown, Robert
Published in Molecular cancer research (01.07.2018)
Published in Molecular cancer research (01.07.2018)
Get full text
Journal Article
Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer
HENNESSY, Bryan T. J, TIMMS, Kirsten M, YANG LI, JIE LI, GONZALEZ-ANGULO, Ana Maria, MCCUNE, Karen Smith, MARKMAN, Maurie, BROADDUS, Russell R, LANCHBURY, Jerry S, LU, Karen H, MILLS, Gordon B, CAREY, Mark S, GUTIN, Alexander, MEYER, Larissa A, FLAKE, Darl D, ABKEVICH, Victor, POTTER, Jennifer, PRUSS, Dmitry, GLENN, Pat
Published in Journal of clinical oncology (01.08.2010)
Published in Journal of clinical oncology (01.08.2010)
Get full text
Journal Article
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial
Rodler, Eve, Sharma, Priyanka, Barlow, William E, Gralow, Julie R, Puhalla, Shannon L, Anders, Carey K, Goldstein, Lori, Tripathy, Debu, Brown-Glaberman, Ursa A, Huynh, Thu-Tam, Szyarto, Christopher S, Godwin, Andrew K, Pathak, Harsh B, Swisher, Elizabeth M, Radke, Marc R, Timms, Kirsten M, Lew, Danika L, Miao, Jieling, Pusztai, Lajos, Hayes, Daniel F, Hortobagyi, Gabriel N
Published in The lancet oncology (01.02.2023)
Published in The lancet oncology (01.02.2023)
Get full text
Journal Article
Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer
Telli, Melinda L., Hellyer, Jessica, Audeh, William, Jensen, Kristin C., Bose, Shikha, Timms, Kirsten M., Gutin, Alexander, Abkevich, Victor, Peterson, Rebecca N., Neff, Chris, Hughes, Elisha, Sangale, Zaina, Jones, Joshua, Hartman, Anne-Renee, Chang, Pei-Jen, Vinayak, Shaveta, Wenstrup, Richard, Ford, James M.
Published in Breast cancer research and treatment (01.04.2018)
Published in Breast cancer research and treatment (01.04.2018)
Get full text
Journal Article
Concordance between an FDA-approved companion diagnostic and an alternative assay kit for assessing homologous recombination deficiency in ovarian cancer
Wehn, Amy K., Qiu, Ping, Lunceford, Jared, Yarunin, Alexander, Cristescu, Razvan, Liu, Li, Roessler, Kyria, Bilke, Sven, Day, John R., Timms, Kirsten M., Weichert, Wilko, Marton, Matthew J.
Published in Gynecologic oncology (01.05.2024)
Published in Gynecologic oncology (01.05.2024)
Get full text
Journal Article
Systematic Analysis of Homologous Recombination Deficiency Testing in Ovarian Cancer—Development of Recommendations for Optimal Assay Performance
Romey, Marcel, Rodepeter, Fiona, Hattesohl, Akira, Kaiser, Kristin, Teply-Szymanski, Julia, Heitz, Florian, Staebler, Annette, Serra, Violeta, Grass, Albert, Marmé, Frederik, Timms, Kirsten M., Harter, Philipp, Llop-Guevara, Alba, Kommoss, Stefan, Boekhoff, Jelena, Denkert, Carsten
Published in Modern pathology (01.04.2024)
Published in Modern pathology (01.04.2024)
Get full text
Journal Article
Tumor BRCA1 Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance
Afghahi, Anosheh, Timms, Kirsten M, Vinayak, Shaveta, Jensen, Kristin C, Kurian, Allison W, Carlson, Robert W, Chang, Pei-Jen, Schackmann, Elizabeth, Hartman, Anne-Renee, Ford, James M, Telli, Melinda L
Published in Clinical cancer research (01.07.2017)
Published in Clinical cancer research (01.07.2017)
Get full text
Journal Article
Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer
Patel, Jai N, Braicu, Ioana, Timms, Kirsten M, Solimeno, Cara, Tshiaba, Placede, Reid, Julia, Lanchbury, Jerry S, Darb-Esfahani, Silvia, Ganapathi, Mahrukh K, Sehouli, Jalid, Ganapathi, Ram N
Published in British journal of cancer (01.10.2018)
Published in British journal of cancer (01.10.2018)
Get full text
Journal Article
Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort: Validation of Decentralized Genomic Profiling
Denkert, Carsten, Romey, Marcel, Swedlund, Brad, Hattesohl, Akira, Teply-Szymanski, Julia, Kommoss, Stefan, Kaiser, Kristin, Staebler, Annette, du Bois, Andreas, Grass, Albert, Knappmeyer, Christiane, Heitz, Florian, Solimeno, Cara, Ebel, Thomas, Harter, Philipp, Marmé, Frederik, Jank, Paul, Gaiser, Timo, Neff, Chris, Wagner, Uwe, Timms, Kirsten M, Rodepeter, Fiona
Published in The Journal of molecular diagnostics : JMD (01.12.2022)
Published in The Journal of molecular diagnostics : JMD (01.12.2022)
Get full text
Journal Article
Genomic and Clinicopathologic Characterization of ATM -deficient Prostate Cancer
Kaur, Harsimar, Salles, Daniela C, Murali, Sanjana, Hicks, Jessica L, Nguyen, Minh, Pritchard, Colin C, De Marzo, Angelo M, Lanchbury, Jerry S, Trock, Bruce J, Isaacs, William B, Timms, Kirsten M, Antonarakis, Emmanuel S, Lotan, Tamara L
Published in Clinical cancer research (15.09.2020)
Published in Clinical cancer research (15.09.2020)
Get full text
Journal Article
BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis
Kalachand, Roshni D, Stordal, Britta, Madden, Stephen, Chandler, Benjamin, Cunningham, Julie, Goode, Ellen L, Ruscito, Ilary, Braicu, Elena I, Sehouli, Jalid, Ignatov, Atanas, Yu, Herbert, Katsaros, Dionyssios, Mills, Gordon B, Lu, Karen H, Carey, Mark S, Timms, Kirsten M, Kupryjanczyk, Jolanta, Rzepecka, Iwona K, Podgorska, Agnieszka, McAlpine, Jessica N, Swisher, Elizabeth M, Bernards, Sarah S, O’Riain, Ciaran, O’Toole, Sharon, O’Leary, John J, Bowtell, David D, Thomas, David M, Prieske, Katharina, Joosse, Simon A, Woelber, Linn, Chaudhry, Parvesh, Häfner, Norman, Runnebaum, Ingo B, Hennessy, Bryan T
Published in JNCI : Journal of the National Cancer Institute (14.12.2020)
Published in JNCI : Journal of the National Cancer Institute (14.12.2020)
Get full text
Journal Article